Table 3. Clinical characteristics of the four major B-cell lymphoma subtypes, with percentages of each characteristic indicated.
| DLBCL (n=642) % |
FL (n=104) % |
MCL (n=30) % |
MZL (n=24) % |
|
|---|---|---|---|---|
| Male | 60 | 54 | 67 | 50 |
| Age > 60 years | 41 | 22 | 33 | 37 |
| CS 3 or 4 | 61 | 75 | 87 | 63 |
| PS > 1 | 16 | 7 | 7 | 4 |
| LDH > N | 52 | 30 | 27 | 21 |
| No. of extranodal sites > 1 | 20 | 11 | 40 | 33 |
| B symptom, present | 24 | 18 | 30 | 21 |
| IPI (HI/H) | 30 | 12 | 27 | 21 |
CS, clinical stage; PS, performance status; IPI, international prognostic index; N, normal; HI/H, high-intermediate risk and high risk